About
Small Molecules for Cancer
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
335
By Phase
PHASE2/PHASE3: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT06624644Lead Sponsor
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
PHASE2/PHASE3Recruiting
135 participants
Started: Aug 6, 2025 · Completed: Feb 28, 2031
NCT04130516Lead Sponsor
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab
PHASE1/PHASE2Recruiting
200 participants
Started: Oct 21, 2019 · Completed: Dec 15, 2027
Funding History (1)
D
Dec 20, 2022
Locations (1)
Headquarters
Haddonfield, NJ, United States
Map
Loading map...